Vitamin E Supplementation and the Risk of Heart Failure in Women

Cardiology Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Circulation Heart Failure (Impact Factor: 5.89). 03/2012; 5(2):176-82. DOI: 10.1161/CIRCHEARTFAILURE.111.963793
Source: PubMed


Oxidative stress may contribute to the development of heart failure (HF); however, an increased risk of HF has been observed with antioxidant therapy in secondary prevention trials. No large clinical trials have addressed the role of antioxidant therapy in the primary prevention of HF.
We examined the effect of vitamin E and HF risk in 39 815 initially healthy women, aged at least 45 years at baseline, who were enrolled in the Women's Health Study, a randomized, double-blind, placebo-controlled trial of vitamin E (600 IU every other day). Over a median follow-up of 10.2 years, there were 220 incident HF events. In proportional hazards models, adjusting for age and randomized aspirin and beta carotene treatment, vitamin E assignment did not significantly affect HF risk (hazards ratio [HR], 0.93; 95% CI, 0.71-1.21; P=0.59). These results did not change with multivariate adjustment for other risk factors, including interim myocardial infarction. In a prespecified subgroup analysis, vitamin E was inversely related to developing HF with normal ejection fraction (≥50%) with HR 0.59 (95% CI, 0.38-0.92; P=0.02), but there was no statistically significant effect on the risk of developing systolic HF (HR, 1.26; 95% CI, 0.84-1.89; P=0.26).
In this population of apparently healthy women, vitamin E did not affect the overall risk of HF. The possible benefit on diastolic HF requires confirmation in larger populations.
URL: Unique identifier: NCT00000479.

  • Source
    • "As a rule of thumb, the ROS effects are multiphasic and bidirectional, depending on the species of oxidants, their concentrations, history of exposure, and cellular context. The proven failure of antioxidant therapies despite decades of industrious efforts [27–30] serves us a humbling lesson on how much we still do not know about ROS signaling. Understanding the cell logic and principles of ROS signaling and developing efficient and specific antioxidant therapies to constrain ROS damages would both hinge on precise and quantitative knowledge of intracellular ROS dynamics, concentrations, compartments, and modes of action. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reactive oxygen species (ROS) act as essential cellular messengers, redox regulators, and, when in excess, oxidative stressors that are widely implicated in pathologies of cancer and cardiovascular and neurodegenerative diseases. Understanding such complexity of the ROS signaling is critically hinged on the ability to visualize and quantify local, compartmental, and global ROS dynamics at high selectivity, sensitivity, and spatiotemporal resolution. The past decade has witnessed significant progress in ROS imaging at levels of intact cells, whole organs or tissues, and even live organisms. In particular, major advances include the development of novel synthetic or genetically encoded fluorescent protein-based ROS indicators, the use of protein indicator-expressing animal models, and the advent of in vivo imaging technology. Innovative ROS imaging has led to important discoveries in ROS signaling-for example, mitochondrial superoxide flashes as elemental ROS signaling events and hydrogen peroxide transients for wound healing. This review aims at providing an update of the current status in ROS imaging, while identifying areas of insufficient knowledge and highlighting emerging research directions.
    Full-text · Article · Jul 2013 · Journal of Molecular Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Over the last two decades, the known functions of the mineralocorticoid receptor (MR) have expanded beyond regulation of sodium and potassium in epithelial cells to encompass physiological and pathophysiological effects in many tissues throughout the body. It is now well accepted that the MR plays a critical role in many aspects of cardiovascular disease. Areas covered: Recent studies employing tissue-selective MR null mice have added valuable insights into the cellular mechanisms that translate MR activation into cardiac remodeling and dysfunction. Together with earlier pharmacological studies using MR antagonists the apparent protective effects of tissue-selective MR deletion support the observed clinical benefits of MR antagonists in heart failure. Given the potential risk of side effects of current therapies, a key goal is the identification of tissue-selective MR antagonists that will provide cardiovascular protection, but spare renal function. As such, the specific cellular mechanisms regulated by MR located in the cardiovascular system may provide the basis for the development of targeted therapies. Expert opinion: This review will address the function of the MR, and its regulation of the cellular mechanisms that determine cell-specific MR signaling in cardiovascular disease and briefly discuss the potential for novel therapeutic targets that will allow for cardiac selective MR blockade.
    No preview · Article · Jan 2013 · Expert Opinion on Therapeutic Targets
  • [Show abstract] [Hide abstract]
    ABSTRACT: Reactive oxygen species (ROS) are emerging as center-stage players in cardiac functional regulation. ROS and Ca2+ signals converge at dyads, the structural and functional units of cardiac excitation-contraction coupling. These two prominent signaling systems are intertwined with ROS modulation of the entire Ca2+-signaling network, and vice versa. While constitutively-generated homeostatic ROS are important in setting the redox potential of the intracellular milieu, dynamic signaling ROS shape microdomain and global Ca2+ signals on both the beat-to-beat and greater time scales. However, ROS effects are complex and subtle, characterized by multiphasic and bidirectional Ca2+ responses; and sustained oxidative stress may lead to compromised contractility and arrhythmogenicity. These new understandings should be leveraged to harness ROS for their beneficial roles while avoiding deleterious effects in the heart.
    No preview · Article · Mar 2013 · Cardiovascular Research
Show more